Related Experiment Videos
Effects of sarcoma 180 growth on interleukin-1 and circulating immune complexes
N A Chasseing1, E M Eugui, E S Borda
1Instituto de Biologia y Medicina Experimental, Buenos Aires, Argentina.
Cancer Investigation
|January 1, 1994
Summary
Immune cells from tumor-bearing mice showed altered interleukin-1 (IL-1) production. Later tumor stages correlated with decreased IL-1, suggesting monocyte dysfunction in tumor-induced immunosuppression.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Immunology
Background:
- Tumor growth can lead to immunosuppression, impairing the host's immune response.
- Monocytes play a crucial role in immune regulation and are implicated in tumor-associated immune evasion.
Purpose of the Study:
- To investigate the impact of tumor growth on interleukin-1 (IL-1) production by splenic mononuclear adherent cells (SMAc).
- To explore the relationship between IL-1 regulation, prostaglandin E2 (PGE2), and immune complexes in tumor-bearing mice.
Main Methods:
- Culturing SMAc from normal and S180 tumor-bearing BALB/c mice.
- Stimulating SMAc with Escherichia coli lipopolysaccharide (LPS) to measure IL-1 production.
- Quantifying PGE2 levels and serum immune complexes at different time points post-tumor challenge.
Main Results:
- SMAc from tumor-bearing mice showed increased LPS-stimulated IL-1 production early after tumor challenge.
- This enhanced IL-1 response diminished at later stages (days 20 and 30) of tumor development.
- Elevated PGE2 and serum immune complexes were observed concurrently with altered IL-1 regulation.
Conclusions:
- Tumor progression affects monocyte function, specifically down-regulating IL-1 production.
- This down-regulation of IL-1 by monocytes may contribute to the immunosuppression observed in later stages of tumor development.
- PGE2 and immune complexes may be involved in the mechanisms underlying tumor-induced immunosuppression.